Furthermore, they showed that combined inhibition of TNF-α, IL-1, and NF-κB in vivo significantly impaired LSC function in the MLL-AF9 mouse model of AML, and prolonged survival in the secondary transplantation setting. This evidence concerns the gene TNF and acute myeloid leukemia.